Daily Signals
2758 companies scored · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
30D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
296 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 30D | Δ | |
|---|---|---|---|---|
| IONSIONIS PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| SYRESpyre Therapeutics, Inc. | Unlock rating and forecasts | |||
| ALKSAlkermes plc. | Unlock rating and forecasts | |||
| PRAXPraxis Precision Medicines, Inc. | Unlock rating and forecasts | |||
| LNTHLantheus Holdings, Inc. | Unlock rating and forecasts | |||
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | Unlock rating and forecasts | |||
| KNSAKiniksa Pharmaceuticals International, plc | -0.41% | ▲ 1 | ||
| AMRXAmneal Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| RYTMRHYTHM PHARMACEUTICALS, INC. | Unlock rating and forecasts | |||
| LGNDLIGAND PHARMACEUTICALS INC | -0.40% | ▲ 1 | ||
| IMVTImmunovant, Inc. | Unlock rating and forecasts | |||
| CGONCG Oncology, Inc. | Unlock rating and forecasts | |||
| MIRMMirum Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| COGTCogent Biosciences, Inc. | -0.04% | · | ||
| PTCTPTC THERAPEUTICS, INC. | Unlock rating and forecasts | |||
| SRRKScholar Rock Holding Corp | Unlock rating and forecasts | |||
| ORKAOruka Therapeutics, Inc. | Unlock rating and forecasts | |||
| CRSPCRISPR Therapeutics AG | Unlock rating and forecasts | |||
| ERASErasca, Inc. | Unlock rating and forecasts | |||
| MANEVeradermics, Inc | Unlock rating and forecasts | |||
| TVTXTravere Therapeutics, Inc. | Unlock rating and forecasts | |||
| DFTXDefinium Therapeutics, Inc. | Unlock rating and forecasts | |||
| EWTXEdgewise Therapeutics, Inc. | Unlock rating and forecasts | |||
| DNTHDianthus Therapeutics, Inc. /DE/ | Unlock rating and forecasts | |||
| ADPTAdaptive Biotechnologies Corp | Unlock rating and forecasts | |||
| INDVIndivior Pharmaceuticals, Inc. | -0.37% | ▲ 1 | ||
| TNGXTango Therapeutics, Inc. | Unlock rating and forecasts | |||
| ARQTArcutis Biotherapeutics, Inc. | Unlock rating and forecasts | |||
| ABCLAbCellera Biologics Inc. | Unlock rating and forecasts | |||
| OGNOrganon & Co. | Unlock rating and forecasts | |||
| TLXTelix Pharmaceuticals Ltd | Unlock rating and forecasts | |||
| RLAYRelay Therapeutics, Inc. | Unlock rating and forecasts | |||
| LEGNLegend Biotech Corp | -0.31% | · | ||
| AMLXAmylyx Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| ACADACADIA PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| XENEXenon Pharmaceuticals Inc. | Unlock rating and forecasts | |||
| IDYAIDEAYA Biosciences, Inc. | Unlock rating and forecasts | |||
| LQDALiquidia Corp | Unlock rating and forecasts | |||
| RCUSArcus Biosciences, Inc. | Unlock rating and forecasts | |||
| ELVNEnliven Therapeutics, Inc. | Unlock rating and forecasts | |||
| ZLABZai Lab Ltd | Unlock rating and forecasts | |||
| NEOGNEOGEN CORP | Unlock rating and forecasts | |||
| NRIXNurix Therapeutics, Inc. | -0.02% | · | ||
| HCMHUTCHMED (China) Ltd | -0.02% | · | ||
| BEAMBeam Therapeutics Inc. | Unlock rating and forecasts | |||
| ADMAADMA BIOLOGICS, INC. | Unlock rating and forecasts | |||
| MBXMBX Biosciences, Inc. | Unlock rating and forecasts | |||
| LIFEaTYR PHARMA INC | Unlock rating and forecasts | |||
| PBHPrestige Consumer Healthcare Inc. | Unlock rating and forecasts | |||
| BHCBausch Health Companies Inc. | -0.08% | · | ||
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.